Latency and reactivation of human cytomegalovirus

被引:291
作者
Sinclair, John [1 ]
Sissons, Patrick [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1099/vir.0.81891-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human cytomegalovirus (HCMV) persists as a subclinical, lifelong infection in the normal human host, maintained at least in part by its carriage in the absence of detectable infectious virus - the hallmark of latent infection. Reactivation from latency in immunocompromised individuals, in contrast, often results in serious disease. Latency and reactivation are defining characteristics of the herpesviruses and key to understanding their biology. However, the precise cellular sites in which HCMV is carried and the mechanisms regulating its latency and reactivation during natural infection remain poorly understood. This review will detail our current knowledge of where HCMV is carried in healthy individuals, which viral genes are expressed upon carriage of the virus and what effect this has on cellular gene expression. It will also address the accumulating evidence suggesting that reactivation of HCMV from latency appears to be linked intrinsically to the differentiation status of the myeloid cell, and how the cellular mechanisms that normally control host gene expression play a critical role in the differential regulation of viral gene expression during latency and reactivation.
引用
收藏
页码:1763 / 1779
页数:17
相关论文
共 148 条
[1]   REPLICATION OF LATENT EPSTEIN-BARR-VIRUS GENOMES IN RAJI CELLS [J].
ADAMS, A .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1743-1746
[2]   MOLECULAR TRANSDUCTIONAL MECHANISMS BY WHICH IFN-GAMMA AND OTHER SIGNALS REGULATE MACROPHAGE DEVELOPMENT [J].
ADAMS, DO ;
HAMILTON, TA .
IMMUNOLOGICAL REVIEWS, 1987, 97 :5-27
[3]  
ADLER SP, 1983, REV INFECT DIS, V5, P977
[4]   Reactivation of Epstein-Barr virus from latency [J].
Amon, W ;
Farrell, PJ .
REVIEWS IN MEDICAL VIROLOGY, 2005, 15 (03) :149-156
[5]  
APPERLEY JF, 1989, EXP HEMATOL, V17, P38
[6]   Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro [J].
Arthur, JL ;
Scarpini, CG ;
Connor, V ;
Lachmann, RH ;
Tolkovsky, AM ;
Efstathiou, S .
JOURNAL OF VIROLOGY, 2001, 75 (08) :3885-3895
[7]   Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee [J].
Arvin, AM ;
Fast, P ;
Myers, M ;
Plotkin, S ;
Rabinovich, R .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :233-239
[8]   Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death [J].
Bain, M ;
Sinclair, J .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 (05) :543-553
[9]   Ets-2 Repressor Factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells [J].
Bain, M ;
Mendelson, M ;
Sinclair, J .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :41-49
[10]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+